Jim Cramer Recently Talked About These 15 Stocks

8. Biohaven Ltd. (NYSE:BHVN)

Number of Hedge Fund Holders: 41

A caller asked for Cramer’s take on Biohaven Ltd. (NYSE:BHVN). Here’s what Mad Money’s host had to say:

“Alright, first, in pure disclosure, Biohaven, I’m working with them. They’ve bought a drug from me, that I made for me, and a terrific guy, Larry Newman, Dr. Newman, to help solve tinnitus so I always want to tell people that. The stock at $21, I think, therefore, is too cheap. But you might say, oh, that’s just Jim talking because he sold his drug to them. But no, I think the stock is very cheap, and Vlad Coric, who’s the CEO, I think, is really terrific. So I would be a buyer of the stock.”

Biohaven (NYSE:BHVN) focuses on discovering, developing, and bringing to market therapies in immunology, neuroscience, and oncology.